E&Investment, Inc.

Insider Reports History

Location
Seoul, Korea, Republic of
Signature
/s/ E&I Investment, Inc., By: Na Yeon Kim, CEO
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by E&Investment, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
NeuroBo Pharmaceuticals, Inc. 10%+ Owner Common Stock 2,890,533 $9,047,368 $3.13 26 Jul 2022 Held by The E&Healthcare Investment Fund II
NeuroBo Pharmaceuticals, Inc. 10%+ Owner Common Stock 1,864,799 $5,836,821 $3.13 26 Jul 2022 Held by The E&Healthcare Investment Fund No. 7
NeuroBo Pharmaceuticals, Inc. 10%+ Owner Common Stock 1,121,190 $3,509,325 $3.13 26 Jul 2022 Held by The E&Healthcare Investment Fund No. 6
NeuroBo Pharmaceuticals, Inc. 10%+ Owner Common Stock 140,147 $438,660 $3.13 26 Jul 2022 Direct

Insider Reports Filed by E&Investment, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MTVA NeuroBo Pharmaceuticals, Inc. 26 Jul 2022 1 $0 4 10%+ Owner 28 Jul 2022, 21:23